SCHEMBL23824904

SCHEMBL23824904

OC=C1c2ccccc2-c2ccccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.41
CYP11B2 P19099 2/20 0.41
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
MAPK1 P28482 2/20 0.38
APAF1 O14727 2/20 0.38
TDP2 O95551 2/20 0.38
KDM4E B2RXH2 1/20 0.38
CES2 O00748 1/20 0.38
TERT O14746 1/20 0.38
NPC1 O15118 1/20 0.38
PLIN1 O60240 1/20 0.38
S1PR4 O95977 1/20 0.38
LMNA P02545 1/20 0.38
PLA2G1B P04054 1/20 0.38
BCHE P06276 1/20 0.38
POLB P06746 1/20 0.38
PTPRC P08575 1/20 0.38
MAPT P10636 1/20 0.38
THRB P10828 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1062220 0.82 KMT2A (0.55) MEN1KMT2AMAPK1APAF1TDP2
SCHEMBL1062217 0.82 KMT2A (0.55) MEN1KMT2AMAPK1APAF1TDP2
SCHEMBL9882800 0.82 KMT2A (0.55) MEN1KMT2AMAPK1APAF1TDP2
SCHEMBL8921288 0.76 CES1 (0.50) CYP19A1CYP11B2MEN1KMT2AKDM4E
SCHEMBL14273165 0.76 MEN1 (0.55) MEN1KMT2AMAPK1APAF1TDP2
SCHEMBL8676274 0.76 CYP19A1 (0.46) CYP19A1CYP11B2MEN1KMT2AMAPK1
SCHEMBL13678920 0.75 KMT2A (0.55) MEN1KMT2AMAPK1APAF1TDP2
SCHEMBL867959 0.71 CYP19A1 (0.60) CYP19A1CYP11B2MEN1KMT2AMAPT
SCHEMBL49870 0.71 MEN1 (0.61) MEN1KMT2AMAPK1APAF1TDP2
SCHEMBL11875421 0.71 MEN1 (0.61) MEN1KMT2AMAPK1APAF1TDP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12351568-B2 Method for producing carbonate derivative NATIONAL UNIVERSITY COPORATION KOBE UNIVERSITY (JP) 2025-07-08 US disclosed
US-20210403409-A1 METHOD FOR PRODUCING CARBONATE DERIVATIVE NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (JP) 2021-12-30 US disclosed
EP-3882231-A1 METHOD FOR PRODUCING CARBONATE DERIVATIVE National University Corporation Kobe University (JP) 2021-09-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12351568-B2 Method for producing carbonate derivative CA4, CA3, CYP11B2 CYP19A1 148/4885CYP11B2 3/4885MEN1 284/4885
US-20210403409-A1 METHOD FOR PRODUCING CARBONATE DERIVATIVE CA4, CA3, CYP11B2 CYP19A1 148/4885CYP11B2 3/4885MEN1 284/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.